Creative Medical Technology Holdings (CELZ) Market Capitalization (2016 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Market Capitalization came in at $1.9 million in Q2 2026, down 45.28% year-over-year from $3.5 million in Q2 2025, and down 29.61% quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
Creative Medical Technology Holdings (CELZ) Market Capitalization (2016 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Market Capitalization for 11 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Market Capitalization fell 45.28% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 45.28% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 15.15% from the prior year.
- Market Capitalization was $1.9 million for Q2 2026 at Creative Medical Technology Holdings, down from $2.7 million in the prior quarter.
- Over five years, Market Capitalization peaked at $25.4 million in Q1 2022 and troughed at $1.9 million in Q2 2026.
- A 5-year average of $5.9 million and a median of $4.8 million in 2024 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization sank 83.35% in 2022 and surged 51.99% in 2023, its largest moves.
- Over 5 years, Market Capitalization stood at $4.2 million in 2022, then surged by 51.99% to $6.3 million in 2023, then sank by 51.49% to $3.1 million in 2024, then declined by 15.15% to $2.6 million in 2025, then decreased by 26.02% to $1.9 million in 2026.
- The last three Market Capitalization figures came in at $1.9 million (Q2 2026), $2.7 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Creative Medical Technology Holdings | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Mn |
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.89 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 7.06 Mn |
| Dec 31, 2023 | 6.33 Mn |
| Sep 30, 2023 | 6.84 Mn |
| Jun 30, 2023 | 6.63 Mn |
| Mar 31, 2023 | 7.04 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 6.19 Mn |
| Jun 30, 2022 | 6.76 Mn |
| Mar 31, 2022 | 25.43 Mn |
| Dec 31, 2021 | 5.76 Mn |
| Sep 30, 2021 | 18.39 Mn |